HTR1B and myeloproliferative neoplasm: In our study, to rule out the possibility of an increased HTR1B expression in lymphocytes of patients with thrombosis in general, unrelated to MPN, we analysed the receptor expression in mononuclear cells obtained from patients with recent thrombosis and no signs of MPN and absence of MPN phenotypic driver mutations.